Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block in Kidney Transplantation
NCT05280197Completed
- Sponsor
- Cleveland Clinic
- Start
- Jan 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in postoperative pain comparing Liposomal Bupivacaine + Bupivacaine with Placebo (2 arms). Primary endpoint: Morphine Milligram Equivalents at Month 12. Started Jan 2022; status: completed.
02
Drugs
liposomal bupivacainebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05280197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05280197.